Article

Heidelberg lauds researcher for aqueous angiography, OCT progress

Alex Huang, MD, PhD, is the winner of the Heidelberg Engineering Xtreme Research Award 2016 for his research on aqueous angiography and OCT structural analysis of outflow pathways.

Seattle-Alex Huang, MD, PhD, is the winner of the Heidelberg Engineering Xtreme Research Award 2016 for his research on aqueous angiography and OCT structural analysis of outflow pathways.

He received the award in a ceremony during ARVO 2016.

SPONSORED: Join us for dinner and diabetes management tips! Click here if you’re attending ASCRS!

Dr. Huang, a glaucoma clinician scientist at the Doheny Eye Institute and at the Department of Ophthalmology, David Geffen School of Medicine, University of California, Los AngeleUCLA in Los Angeles, presented the highlights of his current research in a lecture titled “To See and Touch Aqueous Humor Outflow.”

More glaucoma: Glaucoma gene therapy on positive trajectory using CRISPR-Cas9

With the annual Xtreme Research Award, Heidelberg Engineering recognizes cutting-edge research for the advancement of ophthalmic care.

This year, the award goes to Dr. Huang in recognition for his latest research initiative on structure and function of the anterior segment consisting of a novel method referred to as “aqueous angiography,” which involves dye-based angiography of the anterior chamber and OCT imaging of the outflow pathways using a multimodal imaging platform.

Though still in early stages, Dr. Huang’s research intends to improve glaucoma angle-based procedures by guiding its placement according to the individual anatomy of each eye.

Blog: 5 reasons why physicians still have the best profession

“We are genuinely excited about future possibilities and potential clinical impact that structural and functional anterior segment imaging such as aqueous angiography may have on glaucoma and ophthalmology," Dr. Huang said. "With these tools, one day we may start tailoring glaucoma care to an individual patient's anatomy or patterns of aqueous humor outflow. Thus, this is a real opportunity to learn new biology of the eye as well as push the efficacy of patient care forward.”
 
“Looking ahead, we would like to provide a diagnostic imaging platform to perform dye- based angiography of the anterior segment pre- or intraoperatively and for this reason, we are enthusiastic about Dr. Huang’s research project," said Dr. Kester Nahen, PhD, managing director of Heidelberg Engineering. "Such novel applications of anterior segment research could provide clinically valuable information about aqueous humor flow and flow patterns leading to more effective glaucoma treatment.”

After-hours: DJ ophthalmologists in surgery by day, mixing music by night

Heidelberg Engineering’s development team supports Dr. Huang and other clinicians eager to improve glaucoma treatment outcomes by developing novel anterior segment analyses that combine both the structural and functional aspects using high-end diagnostic imaging equipment.
 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.